NCT06317636View on ClinicalTrials.gov

Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 28, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic PainDepression
Interventions
DRUG

Ketamine

0.5 mg/kg ketamine infused intravenously over 40 minutes

DRUG

Normal saline

0.9% normal saline infused intravenously over 40 minutes

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT06317636 - Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression | Biotech Hunter | Biotech Hunter